IGF1R and esophageal squamous cell carcinoma: The involvement of IGF1R signalling in ESCC is given greater significance by the observation that it also has a role in resistance to conventional chemotherapeutics, shown here in the GO2 trial and also previously with cisplatin, 5-fluorouracil and camptothecin treatments [46, 47].